Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine

Cancer Research

Volumn 59, Issue 17, 1999, Pages 4375-4382

  Sarkaria, Jann N ^a   Busby, Ericka C ^a   Tibbetts, Randal S ^a,b   Roos, Pia ^a   Taya, Yoichi ^c   Karnitz, Larry M ^a   Abraham, Robert T ^a,b,c  

^a MAYO CLINIC   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; DNA DEPENDENT PROTEIN KINASE; RADIOSENSITIZING AGENT;

ARTICLE; ATAXIA TELANGIECTASIA; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; IRRADIATION; LUNG CARCINOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RADIOSENSITIZATION;

EID: 0033199892     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
2. Kirsch, D. G., and Kastan, M. B. Tumor-suppressor p53: implications for tumor development and prognosis. J. Clin. Oncol., 16: 3158-3168, 1998.
3. Giaccia, A. J., and Kastan, M. B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev., 12: 2973-2983, 1998.
4. Prives, C. Signaling to p53: breaking the MDM2-p53 circuit. Cell, 95: 5-8, 1998.
5. Keith, C. T., and Schreiber, S. L. PIK-related kinases: DNA repair, recombination and cell cycle checkpoints. Science (Washington DC), 270: 50-51, 1995.
6. Hoekstra, M. F. Responses to DNA damage and regulation of cell cycle checkpoints by the ATM protein kinase family. Curr. Opin. Genet. Dev., 7: 170-175, 1997.
7. Morgan, S. E., and Kastan, M. B. p53 and ATM: cell cycle, cell death and cancer. Found. Cancer Res., 71: 1-25, 1997.
8. Rotman, G., and Shiloh, Y. ATM: from gene to function. Hum. Mol. Genet., 7: 1555-1563, 1998.
9. Jorgensen, T. J., and Shiloh, Y. The ATM gene and the radiobiology of ataxia-telangiectasia. Int. J. Radiat. Biol., 69: 527-537, 1996.
10. Lavin, M. F., and Shiloh, Y. The genetic defect in ataxia-telangiectasia. Annu. Rev. Immunol., 15: 177-202, 1997.
11. Tibbetts, R. S., Brumbaugh, K. M., Williams, J. M., Sarkaria, J. N., Cliby, W. A., Shieh, S-Y., Taya, Y., Prives, C., and Abraham, R. T. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev., 13: 152-157, 1999.
12. Siliciano, J. D., Canman, C. E., Taya, Y., Sakaguchi, K., Appella, E., and Kastan, M. B. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev., 11: 3471-3481, 1997.
13. Banin, S., Moyal, L., Shieh, S-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., and Ziv, Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science (Washington DC), 281: 1674-1677, 1998.
14. Canman, C. E., Lim, D-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., and Siliciano, J. D. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science (Washington DC), 281: 1677-1679, 1998.
15. Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwinica-Worms, H., and Elledge, S. J. Conservation of the chk1 checkpoint pathway in mammals: linkage of DNA damage to cdk regulation through Cdc25. Science (Washington DC), 277: 1497-1501, 1997.
16. Peng, C-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., and Piwnica-Worms, H. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science (Washington DC), 277: 1501-1505, 1997.
17. Furnari, B., Rhind, N., and Russell, P. Cdc25 mitotic inducer targeted by Chk1 DNA damage checkpoint kinase. Science (Washington DC), 277: 1495-1497, 1997.
18. Matsuoka, S., Huang, M., and Elledge, S. J. Linkage of ATM to the cell cycle regulation by the Chk2 protein kinase. Science (Washington DC), 282: 1893-1897, 1998.
19. Walworth, N. C., and Bernards, R. rad-dependent response of the chk1-encoded protein kinase at the DNA damage checkpoint. Science (Washington DC), 271: 353-356, 1996.
20. Bristow, R. G., Benchimol, S., and Hill, R. P. The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother. Oncol., 40: 197-223, 1996.
21. O'Connor, P. M., and Fan, S. DNA damage checkpoints: implications for cancer therapy. Progr. Cell Cycle Res., 2: 165-173, 1996.
22. Weinert, T. A., Kiser, G. L., and Hartwell, L. H. Mitotic checkpoint genes in budding yeast and the dependence of mitosis on DNA replication and repair. Genes Dev., 8: 652-665, 1994.
23. Wang, Q., Fan, S., Eastman, A., Worland, P. J., Sausville, E. A., and O'Connor, P. M. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. J. Natl. Cancer Inst., 88: 956-965, 1996.
24. cdc2 kinase. Nat. Med., 2: 1140-1143, 1996.
25. 1 checkpoint-competent cells. Cancer Res., 55: 1639-1642, 1995.
26. 2 delay. Cancer Res., 55: 1643-1648, 1995.
27. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
28. Painter, R. B., and Young, B. R. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc. Natl. Acad. Sci. USA, 77: 7315-7317, 1980.
29. Myers, D. K. The initial effect of X-radiation on thymidine incorporation into DNA in thymus cells. Radiat. Res., 47: 731-740, 1971.
30. Tolmach, L. J., Jones, R. W., and Busse, P. M. The action of caffeine on X-irradiated HeLa cells. I. Delayed inhibition of DNA synthesis. Radiat. Res., 71:653-665, 1977.
31. Secrist, J. P., Burns, L. A., Karnitz, L., Koretzky, G. A., and Abraham, R. T. Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events. J. Biol. Chem., 268: 5886-5893, 1993.
32. Brunn, G. J., Hudson, C. C., Sekulic, A., Williams, J. M., Hosoi, H., Houghton, P. J., Lawrence, J. C., Jr., and Abraham, R. T. Phosphorylation of the translational represser PHAS-1 by the mammalian target of rapamycin. Science (Washington DC), 277: 99-101, 1997.
33. Shieh, S-Y., Ikeda, M., Taya, Y., and Prives, C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell, 91: 325-334, 1997.
34. Sarkaria, J. N., Tibbetts, R. S., Busby, E. C., Kennedy, A. P., Hill, D. E., and Abraham, R. T. Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. Cancer Res., 58: 4375-4382, 1998.
35. Sarkaria, J., Gibson, D., Jordan, V., Fowler, J., Lindstrom, M., and Mulcahy, R. Tamoxifen induced increase in the potential doubling time (Tpot) of MCF-7 xenografts as determined by bromodeoxyuridine labeling and flow cytometry. Cancer Res., 53: 4413-4417, 1993.
36. Musk, S. R. R., and Steel, G. G. Override of the radiation-induced mitotic block in human tumour cells by methylxanthines and its relationship to the potentiation of cytotoxicity. Int. J. Radiat. Biol., 57: 1105-1112, 1990.
37. 2-M delay. Clin. Cancer Res., 3: 1149-1156, 1997.
38. Beamish, H., Williams, R., Chen, P., and Lavin, M. F. Defect in multiple cell cycle checkpoints in ataxia-telangiectasia post-irradiation. J. Biol. Chem., 271: 20486-20493, 1996.
39. Maki, C. G., Huibregtse, J. M., and Howley, P. M. In vivo ubiquitination and proteasome-mediated degradation of p53. Cancer Res., 56: 2649-2654, 1996.
40. Brunet, A., and Pouyssegur, J. Mammalian MAP kinase modules: how to transduce specific signals. Essays Biochem., 32: 1-16, 1997.
41. Cliby, W. A., Roberts, C. J., Cimprich, K. A., Stringer, C. M., Lamb, J. R., Schreiber, S. L., and Friend, S. H. Overexpression of a kinase-inactive ATR protein causes sensitivity to DMA-damaging agents and defects in cell cycle checkpoints. EMBO J., 17: 159-169, 1998.
42. 2 arrest. Radiat. Res., 113: 58-70, 1988.
43. DeFrank, J. S., Tang, W., and Powell, S. N. p53-null cells are more sensitive to ultraviolet light only in the presence of caffeine. Cancer Res., 56: 5365-5368, 1996.
44. Zampetti-Bosseler, F., and Scott, D. The effect of caffeine on X-ray-induced mitotic delay in normal human and ataxia-telangiectasia fibroblasts. Mutat. Res., 143: 251-256, 1985.
45. 2 on X-ray-induced chromosomal aberrations and mitotic inhibition in ataxia telangiectasia fibroblast and lymphoblastoid cells. Hum. Genet., 67: 329-335, 1984.
46. Holstein, M., Rice, K., Greenblatt, M. S., Soussi, T., Fuchs, R., Sorlie, T., Hovig, E., Smith-Sorenson, B., Montesano, R., and Harris, C. C. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res., 22: 3551-3555, 1994.
47. 2 arrest after DNA damage. Science (Washington DC), 282: 1497-1501, 1998.
48. 1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA, 92: 8493-8497, 1995.
49. Hermeking, H., Lengauer, C., Polyak, K., He, T-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., and Vogelstein, B. 14-3-3σ is a p53-regulated inhibitor of G2/M progression. Mol. Cell., 1: 3-11, 1997.
50. 2/M by p53. Oncogene, 10: 109-115, 1995.
51. 2 arrest in human cells. Oncogene, 17: 673-684, 1998.
52. Waldman, T., Lengauer, C., Kinzler, K. W., and Vogelstein, B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature (Lond.), 381: 713-716, 1996.
53. Waldman, T., Zhang, Y., Dillehay, L., Yu, J., Kinzler, K., Vogelstein, B., and Williams, J. Cell-cycle arrest versus cell death in cancer therapy. Nat. Med., 3: 1034-1036, 1997.